
At Ostro, we don’t make new medicines, but we like to say that our talent is making medicine make sense.

The pharma sector faces a critical challenge: bridging the widening digital divide. To keep pace with rapid technological advancements, companies need to break down silos and integrate their digital initiatives, ensuring a seamless and effective approach to innovation.

On its 10th anniversary, Exact Sciences' Cologuard, a noninvasive, at-home alternative to colonoscopy, is a prime example of how consumerization can apply to diagnostics.

How does a CEO transform a neuroscience-focused biopharma company into a pioneering leader in treating stigmatized conditions?

Learn how Dermavant is partnering with Ostro to use AI and high-touch engagement to elevate and personalize the patient journey.

If the past decade is any indication, the future for Vertex - and the patient communities it is seeking to support - looks promising indeed.

Exact Sciences in Forbes: An Innovative Approach to Consumerization